BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//RE4CH - ECPv6.1.2.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:RE4CH
X-ORIGINAL-URL:https://www.research-for-children.de
X-WR-CALDESC:Events for RE4CH
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20200218T000000
DTEND;TZID=Europe/Berlin:20200218T235900
DTSTAMP:20260820T214600
CREATED:20200113T082839Z
LAST-MODIFIED:20200113T122817Z
UID:1375-1581984000-1582070340@www.research-for-children.de
SUMMARY:EJP RD Joint Transnational Call: “Pre-clinical Research to Develop Effective Therapies for Rare Diseases”
DESCRIPTION:The ERA-Net E-Rare has successfully implemented ten Joint \nTransnational Calls for rare disease research projects since 2006. This \neffort continues in the framework of the European Joint Programme on Rare Diseases (EJP RD)\n that has been established to further help in coordinating the research \nefforts of European\, Associated and non-European countries in the field \nof rare diseases and implement the objectives of the International Rare Disease Research Consortium (IRDiRC). \n\n\n\nThe aim of the call is to enable scientists in different countries to build an effective collaboration on a common interdisciplinary research project based on complementarities and sharing of expertise\, with a clear future benefit for patients. \n\n\n\nThe deadline for registration and submission of pre-proposals is the 18th of February 2020.  \n\n\n\nResearch proposals must cover at least one of the following areas: \n\n\n\nDevelopment of novel therapies in a preclinical setting (including \nsmall molecules\, repurposing drugs\, cell and gene advanced therapies) \nfocusing on condition(s) with unmet medical needsUse of disease models suitable for medicinal product’s development according to EMA guidelinesDevelopment of predictive and pharmacodynamics (PD) biomarkers (with\n appropriate analytical methods e.g. OMICS) in a preclinical setting \n(e.g. in the validated model or in pre-collected human samples) for \nmonitoring the efficiency of the therapy. The model chosen must mimic \nthe human diseases and be transposable so that the biomarker identified \nin animals can be valid for humansProof of principle studies fostering an early (pre-clinical) stage \nof drug development (excluding interventional clinical trials of phase \n1-4).\n\n\n\nThe following approaches and topics are excluded from the scope of the call: \n\n\n\nTherapeutic approaches concerning rare infectious diseases\, rare  cancers and rare adverse drug events in treatments of common diseasesInterventional clinical trialsSurgery or radiation therapiesStudies that focus on research to accelerate diagnosis or to set up  new registry/cohort studies to explore disease progression and  mechanisms as these were the focus of JTC 2019.Rare neurodegenerative diseases which are within the main focus of the Joint Programming Initiative on Neurodegenerative Disease Research (JPND).  These are: Alzheimer’s disease and other dementias; Parkinson’s disease  (PD) and PD-related disorders; Prion disease; Motor Neuron Diseases;  Huntington’s disease; Spinal Muscular Atrophy and dominant forms of  Spinocerebellar Ataxia.  Interested researchers should refer to the  relevant JPND calls.       Childhood dementias/neurodegenerative diseases are not excluded.\n\n\n\nFor more information\, please visit the EJP RD webpage here.
URL:https://www.research-for-children.de/event/ejp-rd-joint-transnational-call-pre-clinical-research-to-develop-effective-therapies-for-rare-diseases/
CATEGORIES:Funding Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20200218T120000
DTEND;TZID=Europe/Berlin:20200218T130000
DTSTAMP:20260820T214600
CREATED:20200205T122246Z
LAST-MODIFIED:20200205T122325Z
UID:1525-1582027200-1582030800@www.research-for-children.de
SUMMARY:CIBSS Seminar: “Opto-chemical control of immune cell activation and signalling dynamics (John James\, Warwick)
DESCRIPTION:Speaker: Dr. John James (Warwick Medical School\, UK) \n\n\n\nHost: Prof. Dr. Maja Köhn (Institute of Biology III) \n\n\n\nLocation: SR 00.023\, Signalhaus Freiburg\, Schänzlestr 18\, 79104 Freiburg  \n\n\n\nhttps://www.cibss.uni-freiburg.de/events/cibss-seminar-series/1802-cibss-seminar/
URL:https://www.research-for-children.de/event/cibss-seminar-opto-chemical-control-of-immune-cell-activation-and-signalling-dynamics-john-james-warwick/
CATEGORIES:Seminars, talks, and training events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20200218T140000
DTEND;TZID=Europe/Berlin:20200218T150000
DTSTAMP:20260820T214600
CREATED:20200205T122851Z
LAST-MODIFIED:20200205T122856Z
UID:1527-1582034400-1582038000@www.research-for-children.de
SUMMARY:NeuroMAC: The role of progranulin in microglial phagocytosis of apoptotic cells (Lis de Weer\, Calgary)
DESCRIPTION:Talk by Lis de Weer (University of Calgary\, Alberta\, Canada) on The Role of progranulin in microglial phagocytosis of apoptotic cells. \n\n\n\nLocation:   Konferenzraum 2 – Neurozentrum\, Breisacher Str. 64\, Freiburg  \n\n\n\nHost: Marco Prinz \n\n\n\n\nNeuroMac Lecture Series Freiburg – Lis de Weerd
URL:https://www.research-for-children.de/event/neuromac-the-role-of-progranulin-in-microglial-phagocytosis-of-apoptotic-cells-lis-de-weer-calgary/
CATEGORIES:Seminars, talks, and training events
END:VEVENT
END:VCALENDAR